PLUM ALLEY VENTURE FUND
Q1 2020 Private and Confidential
$24 MILLION INVESTED THUS FAR We invest in prime companies that have advanced new technologies and medical breakthroughs that will improve our lives and the planet. These are some of the companies we have invested in and the problems they solve.Everyone of these companies has a product with massive market potential and a powerful business model.
INVEST WITH
2
$24 MILLION INVESTED—WHAT TO KNOW 19 companies - 100% with advanced technology or medical breakthroughs Amount invested $500k
to $3.75 million in an individual syndicate
65% Series A 25% Series B 10% late Seed
100% with at least one woman founder 47% with men and women in founding team 100% of companies in the STEM fields $350 million raised in aggregate since 2016 by our companies Companies funded in these years have (as of 1/2020): 2016 75% raised next round and 1 exit
60% raised next round 2018 60% raised next round 2017
INVEST WITH
Next rounds at average valuation increase of 3X
3
TOP LEADERSHIP IN OUR FIRM: WE ARE INVESTORS, ENTREPRENEURS, OPERATORS AND EXPERTS IN RASING CAPITAL IN PRIVATE AND PUBLIC MARKETS DEBORAH JACKSON FOUNDER & CEO
30 years raising capital in public and private markets 10 year Entrepreneur and founder of 2 companies Investor in over 40 early stage companies
ANDREA TURNER
CO-FOUNDER & PRESIDENT
20+ years as Investment Banker in Tech Broad capital markets experience Entrepreneur Speaker and Author
AVANTIKA DAING INVESTMENT PARTNER
25 years as Founder, operator and investor in SaaS companies, healthcare and biotech. M&A and IPO Experience
INVEST WITH
44
PLUM ALLEY INVESTED $24 MILLION IN 19 COMPANIES We operate like a venture firm identifying, evaluating and selecting founders, technologies and companies that meet our strict criteria. We cast a wide net to find the best and leverage our relationships on both coasts and across the country which brings differentiated value to both investors and founders. Our investors are:
Corporate Executives Directors of Public Companies Founders of Firms Family Offices Philanthropist Investors We track and have evaluated over 700 extraordinary companies. We have secured allocation in highly competitive offerings, not available without Plum Alley, because of the support and advice we give to founders. We are seeking LPs to invest in our Fund and/or Co-Investors to invest with us.
INVEST WITH
5
MEET SOME OF OUR INVESTORS Our investors are from a broad range of industries that dive our economy like health care, pharmaceutical, financial services, energy companies, consumer products, agriculture, etc. Our investors have high value credentials and relationships that are not easy for founders to access. They can make the difference between getting an introduction or partnership or not. Our investors bring new resources, insights and often challenge “group think” to drive faster market adoption across industries.
RICHARD WITTEN Former Goldman Partner Special Advisor to Lee Bollinger, Columbia University
DIANA TAYLOR Corporate Director Citigroup, Sothebys, Brookfield Asset Management, Mayo Clinic
BRIDGETTE HELLER President, Danone Nutricia Former Exec, J&J, Merck Corporate DirectorTech Data
HOWARD MORGAN Founder, First Round Capital Chair, B Capital, CoFounder Renaissance Technologies
MARY BYRON Former Head of Technology Goldman Sachs Federation Board- Room to Read, Board Chair Auburn Theological
PAUL CAINE President, NFL On Location Experiences, PC Ventures, Former Executive Time Inc & Bloomberg Media
LEIGH ANNE BAKER SR Corp VP Cargill Corporate Director ABM
MONA SINHA Chair of Trustees- Smith College Chair-Women Moving Millions Ravi-Vice Chair, Bank of America
JERI FINARD Former President, Godiva Corporate Director - Hex, Serta Simmons & Seventh Generation
JAYESH PUNETAR Founder, Nucleus Data Former Founder & CEO, Gravitas
MARISSA WESLEY Former Partner, Simpson Thatcher Chair - Global Council - Women Win Global Fellow -The Wilson Center Fellow- Harvard Advanced Leadership
ELIZABETH BRADLEY Former Executive, Netflix
JAY GELLERT Former CEO, Healthnet Corporate Director Ventas, Inc.
JONI BESSLER Entrepreneur, Former Booz Allen Partner, China
CONNIE MOORE Former CEO, BRE Properties Corporate DirectorColumbia Property Trust, Tri Pointe Group
JEFF ALTMAN Family Office Founder & Managing Partner Owl Creek Asset Management
BRENDA HARVEY Executive & General Manager, IBM
MARGARET HEARST Board Conscious Media
TONY DUB Founder Indigo Capital, Former Officer, Credit Suisse and IB Head Chairman, Capital IQ
BARBARA SHATTUCK KOHN Founder Shattuck Hammond Partners Corporate Director Sun Life, Penn Gaming, Tufts Health
JEFFREY HALIS Founder, Tyndall Management Board MIT Corporation
6
WE GET BEHIND OUR COMPANIES WITH MORE THAN MONEY We advise them on the capital markets and facilitate meaningful relationships in the C-suite. The following are examples of relationships we facilitated with founders that resulted in investment, strategic partnerships or a new customer.
INVEST WITH
7
WE INVEST IN COMPANIES THAT USE MORE THAN ONE TECHNOLOGY TO BRING EXPONENTIAL VALUE Ubiquitous Sensors and Connected Networks Digital Health Intelligence & Smart Machines Robotics Blockchains and Verification 3D Printing for health and components Drone and satellite capability
INVEST WITH
8
MEET SOME OF OUR FOUNDERS We believe diversity of thought contributes to the success of a company and diversity of investors brings rigorous evaluation of opportunities making for better outcomes. A broad range of investors brings advocates and adopters across demographics and industries. We are champions of women founders in the STEM fields and teams of women and men. We invest in founders, new solutions to old problems and companies that can reach global scale.
Davida Hertzl, C0-Founder and CEO
Trevor Martin, Co-founder and CEO, Dr Jennifer Doudna, Co-Founder
Jake Soberal & Irma Olguin Jr, Co-Founders and CEOs
Meena Sankaran, Founder and CEO
INVEST WITH
9
OUR INVESTMENTS REACHING MILESTONES AND SCALE
EINRIDE launches commercial
ACLIMA and Google partner
EPIBONE receives FDA clearance
globally to map world’s air pollution with Street View cars
First-In-Human, Phase 1/2 Trial of bone product
MAMMOTH BIOSCIENCES
BITWISE INDUSTRIES turned
announces partnership with
Fresno into a thriving tech hub
Stella McCartney
granted 2 priority Patents for CRISPR diagnostics
TINKERGARTEN receives
KETOS This startup seeks to
VITAL VIO New 50-page
pilot of driverless electric pods with Coca-Cola Europe Partners
EVRNU recycled fabrics
$21 million from Jeffrey Katzenberg’s WndrCo
identify water problems before they become crises
Research Report on Germs Featured in Forbes
INVEST WITH
10 10
WHERE OUR PLUM ALLEY INVESTORS AND COMPANIES ARE LOCATED AND SOME VENTURE FIRMS WE CO-INVEST WITH Plum Alley investing with: Location of Plum Alley Investors
Headquartered in Sweden
expanding to U.S. market
INVEST WITH
11 11
PLUM ALLEY VENTURE FUND FOCUS IS “MORE OF THE SAME� 70% Advanced Technology and 30% Health Related $1M to $2M invested per company Fund deployed over 3-4 years 35-40% reserved for next rounds 2.5% management fee* and 20% carried interest Target return of 3-5x in approx. 7 years Minimum Investment: $5M Institution/$1M Individual Fund target of $50 million with total investment of $100 million including our Co-Investor syndicates
INVEST WITH
*2.5% Management Fee during investment period which drops by 0.25% per year at 4th year for weighted average of 2% over fund life.
12
PLUM ALLEY COMPANIES REACHING 6 BILLION+ PEOPLE WORLDWIDE
13
WHAT FORMS OUR INVESTMENT THESIS Technology advances and medical breakthroughs will dominate our future. Risk factors are changing with climate change and globalization. Risk must be measured constantly against outcomes and return. We consider unintended consequences when we evaluate innovations. Diversity of thought matters and diversity of investors brings optimal return.
INVEST WITH
14 14 - Š 2018 Plum Alley Co. PRIVATE AND CONFIDENTIAL
LEADING THE WAY TO INSPIRE NEW INVESTORS
Print Edition June 2018
PLUM ALLEY FEATURED SPEAKING ENGAGEMENTS:
INVEST WITH
15
Disclosure Statement
This presentation is supplied to you in connection with your proposed investment in Plum Alley Ventures Fund I, L.P. (the "Fund") and provides certain confidential information. This presentation does not constitute an offering of interests in the Fund, and any interests in the Fund are being offered solely on the basis of the Fund's limited partnership agreement and subscription materials. Do not copy or distribute. Proprietary and Confidential.
Past performance of assets disclosed in this presentation is no guarantee, projection or prediction and is not necessarily indicative of future results, and there can be no assurance that targeted or projected returns will be achieved, or that any current or future Plum Alley (such term includes Plum Alley Ventures Fund I, LP and Plum Alley Ventures, LLC) investment will achieve comparable results. Targeted returns set forth herein may not be meaningful, are being shown for information purposes only and should not be relied upon to make predictions of actual future performances or construed as providing any assurance as to the results that may be realized in the future from investments. Actual returns will depend on a variety of factors, all of which are inherently uncertain and may differ materially from the assumptions and circumstances on which the valuations used in the prior performance data contained herein are based. The Plum Alley Ventures Fund I and its general partner and Plum Alley Management, LLC (together “Plum Alley Ventures”), are newly formed entities, and each has a limited operating history. Confidentiality: This document is confidential information and includes material proprietary non-public information respecting Plum Alley and its investment activities. By acceptance hereof, recipient agrees to receive and maintain such information in a confidential manner and to neither use any such information to the competitive detriment of Plum Alley nor disclose any such information to any third party (other than its tax and legal advisors as necessary). Further, by accepting this information, the recipient agrees that it will not use, and it will cause its directors, partners, officers, employees, and representatives not to use, the information in a manner inconsistent with applicable securities laws. Any reproduction of this information, in whole or in part, is prohibited. Not an Offer to Sell: Plum Alley has prepared this document solely to provide an overview of its proposed fund investments. This document is not an offer or solicitation to purchase securities or invest, and
to ignitemay many more women because it funds advised, sponsored, or raised by Plum Alley. Any offer or solicitation with respect to any fund, not be used or relied investors upon in connection especially with any offer or solicitation with respect to any investment if made, will be made only through a limited partnership or similar agreement and subscription materials in respect of any investment fund. The final agreement, and potentially an offering memorandum, atters. will be available to qualified investors upon request and will contain, among other things, a description of the risks associated with such an investment. No Warranty: Certain information contained herein has been obtained from published sources and from third parties, including without limitation, market forecasts, market research, publicly available information, and industry publications. Neither Plum Alley nor any of its respective advisors, agents, affiliates, partners, members, or employees assume responsibility for or make any representation or
This presentation is supplied to you in connection with your proposed investment in Plum Alley Ventures Fund I, L.P. (the "Fund") and provides certain confidential information on its investment adviser. This presentation does not constitute an offering of interests in the Fund, and any interests in the Fund are being offered solely on the basis of the Fund's limited partnership agreement and subscription materials. Do not copy or distribute. in Proprietary and Confidential. warranty, express or implied, with respect to the accuracy, adequacy or completeness of the information contained this document.
Information Not Complete: This document does not purport to be all inclusive nor to contain all the information that a prospective investor could desire when considering investing in any fund or syndicate sponsored by Plum Alley and each potential investor considering an investment in any such fund must conduct and rely on its own evaluation thereof, including the merits and risks involved. Each potential investor should consult its own attorney, business advisor and tax advisor as to legal, business, tax and related matters concerning the information contained herein, as appropriate. Information Subject to Change without Notice: This document is qualified in its entirety by reference to any future memorandum or notice of change investment objectives and strategy, and all the information presented herein is subject to change without notice to you or any other recipient hereof. Projections May Not Materialize: Except as otherwise indicated, this document speaks as of the date hereof. The delivery of this document shall not, under any circumstances, create any implication that there has been no change in the affairs of Plum Alley or its related entities after the date hereof. This document may contain forward-looking statements that involve risks and uncertainties. You can identify these forward-looking statements by reference to words such as “believes”, “potential”, “may”, “seeks”, or other comparable words and phrases. Actual results may differ materially from expectations discussed in such forward-looking statements. There can be no assurance that Plum Alley will be able to implement its investment strategy or achieve its investment objective. Except as required by law, Plum Alley does not assume any obligation to correct or update the historical, forward-looking, or other information contained in this document. Other Considerations: The distribution of this document in certain jurisdictions may be restricted by law and it is the responsibility of the recipient hereof to ensure compliance with such laws.
16